Detalles de la búsqueda
1.
Well-being trajectories in breast cancer and their predictors: A machine-learning approach.
Psychooncology
; 32(11): 1762-1770, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830776
2.
Personalized Risk Analysis to Improve the Psychological Resilience of Women Undergoing Treatment for Breast Cancer: Development of a Machine Learning-Driven Clinical Decision Support Tool.
J Med Internet Res
; 25: e43838, 2023 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307043
3.
Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer.
Breast J
; 2022: 9921575, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474966
4.
Cognitive, emotional, and behavioral mediators of the impact of coping self-efficacy on adaptation to breast cancer: An international prospective study.
Psychooncology
; 30(9): 1555-1562, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998100
5.
Negative affect and stress-related brain metabolism in patients with metastatic breast cancer.
Cancer
; 126(13): 3122-3131, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286691
6.
Can mindfulness facilitate posttraumatic growth in breast cancer patients? The mediating role of illness perceptions and positive emotions.
J Health Psychol
; 29(5): 438-451, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38312012
7.
Greater perceived stress management skills and heightened brain metabolic activity in cortical and subcortical stress processing regions in metastatic breast cancer patients.
Brain Imaging Behav
; 18(1): 130-140, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950083
8.
Protective Factors against Fear of Cancer Recurrence in Breast Cancer Patients: A Latent Growth Model.
Cancers (Basel)
; 15(18)2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760558
9.
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care.
Eur J Cancer
; 187: 105-113, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146504
10.
Trajectories of Quality of Life among an International Sample of Women during the First Year after the Diagnosis of Early Breast Cancer: A Latent Growth Curve Analysis.
Cancers (Basel)
; 15(7)2023 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046622
11.
Psychological and somatic symptoms among breast cancer patients in four European countries: A cross-lagged panel model.
Stress Health
; 39(2): 474-482, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35997497
12.
Personalized prediction of one-year mental health deterioration using adaptive learning algorithms: a multicenter breast cancer prospective study.
Sci Rep
; 13(1): 7059, 2023 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120428
13.
Cross-Cultural Adaptation and Psychometric Evaluation of the Perceived Ability to Cope With Trauma Scale in Portuguese Patients With Breast Cancer.
Front Psychol
; 13: 800285, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35250735
14.
Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients.
Brain Behav Immun Health
; 21: 100433, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243410
15.
The moderating role of coping flexibility in reports of somatic symptoms among early breast cancer patients.
Soc Sci Med
; 308: 115219, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863152
16.
Cross-cultural adaptation and psychometric evaluation of the Portuguese version of the family resilience questionnaire - short form (FaRE-SF-P) in women with breast cancer.
Front Psychol
; 13: 1022399, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733863
17.
Trajectories and Predictors of Depression After Breast Cancer Diagnosis: A 1-year longitudinal study.
Annu Int Conf IEEE Eng Med Biol Soc
; 2022: 69-72, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36085801
18.
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
J Geriatr Oncol
; 13(5): 582-593, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101364
19.
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression.
Breast
; 64: 100-111, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636341
20.
Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo - Neotarget Trial.
Breast Care (Basel)
; 17(2): 166-171, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35707179